MIRA Pharmaceuticals Inc.

NASDAQ: MIRA · Real-Time Price · USD
1.51
0.04 (2.72%)
At close: Aug 15, 2025, 3:59 PM
1.48
-1.97%
After-hours: Aug 15, 2025, 07:51 PM EDT

MIRA Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-7.85M -11.98K -7.06M -2.18M
Depreciation & Amortization
n/a 732.29K n/a n/a
Stock-Based Compensation
1.92M 2.55M 1.3M n/a
Other Working Capital
174.6K 390.38K 146.58K 776.01K
Other Non-Cash Items
n/a -9.31M 10.25K 24.37K
Deferred Income Tax
n/a 401.39K n/a n/a
Change in Working Capital
371.25K 849.93 146.58K 776.01K
Operating Cash Flow
-5.56M -5.63M -5.6M -1.38M
Capital Expenditures
n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
n/a n/a n/a n/a
Debt Repayment
n/a 2.11M -160K 203.06K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
182.42K 8.78K 402.19K -520.85K
Financial Cash Flow
3.79M 9.88M 3.15M 4.18M
Net Cash Flow
-1.77M 4.25K -2.46M 2.81M
Free Cash Flow
-5.56M -4.53K -5.6M -1.38M